Surgical intervention to help manage or even reverse type 2 diabetes has gained credence in recent years. This course looks at the theory and the practice.
This course examines hypoglycaemia, a complication of therapy that has a profound impact on the day-to-day lives and well-being of people who treat their diabetes with insulin.
Therapeutic inertia has been implicated as a significant contributory factor in suboptimal diabetes management. This course explores the phenomenon – defined as the failure to advance or de-intensify therapy when appropriate.
From obscure origins in studies of lizard saliva, GLP-1 receptor agonists (GLP-1RAs) have become a staple of type 2 diabetes treatment. This course examines the ways in which they can aid type 2 diabetes management.
Transplants of insulin-producing islets offer the hope of glucose regulation without daily insulin injections. This course looks at advances in this exciting field of diabetes treatment and the challenges still to come.
This course introduces you to the current unmet need in type 1 diabetes and explores trial data in the use of adjunct therapies including pramlintide, metformin, liraglutide and SGLT-2 inhibitors.